Grants and Contributions:
Title:
Purification of an active ingredient for the development of a targeted cancer therapy
Agreement Number:
973093
Agreement Value:
$71,275.00
Agreement Date:
May 31, 2021 - Mar 1, 2023
Description:
This project aims to develop a set of extraction and purification methods to obtain an active principle, which will be used in the development process of a targeted therapy for cancer.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Moncton, New Brunswick, CA E1C 5R2
Reference Number:
172-2021-2022-Q1-973093
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
831651336
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 213 days.
Amendment Date
Sep 22, 2022
Recipient's Legal Name:
Biomolecules for life Inc.
Federal Riding Name:
Moncton--Riverview--Dieppe
Federal Riding Number:
13007
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: